SINGLE NUCLEOTIDE POLYMORPHISM IN KIR2DL1 IS ASSOCIATED WITH HLA-C EXPRESSION IN GLOBAL POPULATIONS

被引:0
|
作者
Vargas, Luciana B. [1 ]
Dourado, Renata M. [1 ]
Amorim, Leonardo M. [1 ]
Ho, Brenda [2 ]
Calonga-Solis, Veronica [1 ]
Issler, Hellen C. [1 ]
Marin, Wesley M. [2 ]
Beltrame, Marcia H. [1 ]
Petzl-Erler, Maria Luiza [1 ]
Hollenbach, Jill A. [2 ]
Augusto, Danillo G. [2 ]
机构
[1] Univ Fed Parana, Curitiba, Parana, Brazil
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
OR70
引用
收藏
页码:17 / 17
页数:1
相关论文
共 50 条
  • [1] Single Nucleotide Polymorphism in KIR2DL1 Is Associated With HLA-C Expression in Global Populations
    Vargas, Luciana de Brito
    Dourado, Renata M.
    Amorim, Leonardo M.
    Ho, Brenda
    Calonga-Solis, Veronica
    Issler, Hellen C.
    Marin, Wesley M.
    Beltrame, Marcia H.
    Petzl-Erler, Maria Luiza
    Hollenbach, Jill A.
    Augusto, Danillo G.
    [J]. FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [2] THE CHARACTERISTICS OF KIR2DL1 ALLELES POLYMORPHISM AND RECOGNITION HLA-C LIGAND IN THE CHINESE HAN POPULATION
    He, Jun
    Wang, Miao
    Bao, Xiaojing
    Zhang, Jiang
    [J]. HUMAN IMMUNOLOGY, 2014, 75 : 92 - 92
  • [3] The characteristics of frequency distribution of KIR2DL1 alleles polymorphism and recognition HLA-C ligand in the Chinese Han population
    王苗
    [J]. China Medical Abstracts (Internal Medicine), 2014, 31 (01) : 52 - 52
  • [4] Incompatibility between KIR2DL1 and its HLA-C ligands is associated with acute rejection in kidney transplantation
    Seiler, M
    Schoenemann, C
    Mashreghi, MF
    Reinke, P
    Volk, HD
    Kotsch, K
    [J]. HUMAN IMMUNOLOGY, 2005, 66 : S58 - S58
  • [5] Different Selected Mechanisms Attenuated the Inhibitory Interaction of KIR2DL1 with C2+ HLA-C in Two Indigenous Human Populations in Southern Africa
    Nemat-Gorgani, Neda
    Hilton, Hugo G.
    Henn, Brenna M.
    Lin, Meng
    Gignoux, Christopher R.
    Myrick, Justin W.
    Werely, Cedric J.
    Granka, Julie M.
    Moeller, Mario
    Hoa, Eileen G.
    Yawata, Makoto
    Yawata, Nobuyo
    Boelen, Lies
    Asquith, Becca
    Parham, Peter
    Norman, Paul J.
    [J]. JOURNAL OF IMMUNOLOGY, 2018, 200 (08): : 2640 - 2655
  • [6] Characterization of KIR+ NK cell subsets with a monoclonal antibody selectively recognizing KIR2DL1 and blocking the specific interaction with HLA-C
    Meazza, Raffaella
    Falco, Michela
    Canevali, Paolo
    Loiacono, Fabrizio
    Colomar-Carando, Natalia
    Muntasell, Aura
    Rea, Anna
    Mingari, Maria Cristina
    Locatelli, Franco
    Moretta, Lorenzo
    Lopez-Botet, Miguel
    Pende, Daniela
    [J]. HLA, 2022, 100 (02) : 119 - 132
  • [7] A SINGLE NUCLEOTIDE POLYMORPHISM LOCATED IN THE HLA-C PROMOTER REGION AND DETERMINING HLA-C EXPRESSION LEVELS IS ASSOCIATED WITH HEPATITIS C VIRUS CONTROL
    Heinemann, Falko M.
    Lindemann, Monika
    Thoens, Christine
    Horn, Peter A.
    Timm, Joerg
    Heinold, Andreas
    [J]. TISSUE ANTIGENS, 2015, 85 (05): : 317 - 317
  • [8] Allelic polymorphism, mRNA and antigen expression of KIR2DL1 in the Chinese Han population
    He, Yanmin
    Tao, Sudan
    Ying, Yanling
    He, Ji
    Zhu, Faming
    Lv, Hangjun
    [J]. HUMAN IMMUNOLOGY, 2014, 75 (03) : 245 - 249
  • [9] Conjunctival Scarring in Trachoma Is Associated with the HLA-C Ligand of KIR and Is Exacerbated by Heterozygosity at KIR2DL2/KIR2DL3
    Roberts, Chrissy H.
    Molina, Sandra
    Makalo, Pateh
    Joof, Hassan
    Harding-Esch, Emma M.
    Burr, Sarah E.
    Mabey, David C. W.
    Bailey, Robin L.
    Burton, Matthew J.
    Holland, Martin J.
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2014, 8 (03):
  • [10] KIR2DL1*003 with HLA-C2 protects from amyotrophic lateral sclerosis
    Ramey, Grace
    Augusto, Danillo
    Marin, Wesley
    Amorim, Leonardo
    Yusufali, Tasneem
    Kichula, Katherine
    Montero-Martin, Gonzalo
    Caillier, Stacy
    Santaniello, Adam
    Fernandez-Vina, Marcelo
    Norman, Paul
    Oksenberg, Jorge
    Hollenbach, Jill
    [J]. HLA, 2022, 99 (05) : 506 - 507